表紙
市場調査レポート

世界の癌診断検査市場の分析:新興の検査、技術の評価、装置レビュー、売上高予測(国別)、主要サプライヤーの戦略的プロファイル

2016-2020 Global Tumor Marker Testing Market: Supplier Shares by Test, Country Volume & Sales Segment Forecasts, Innovative Technologies, Instrumentation Review, Competitive Strategies, Emerging Opportunities-France, Germany, Italy, Japan, Spain, UK, US

発行 Venture Planning Group 商品コード 261390
出版日 ページ情報 英文 1200 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=107.50円で換算しております。

Local License: 同一事業所内

Back to Top
世界の癌診断検査市場の分析:新興の検査、技術の評価、装置レビュー、売上高予測(国別)、主要サプライヤーの戦略的プロファイル 2016-2020 Global Tumor Marker Testing Market: Supplier Shares by Test, Country Volume & Sales Segment Forecasts, Innovative Technologies, Instrumentation Review, Competitive Strategies, Emerging Opportunities-France, Germany, Italy, Japan, Spain, UK, US
出版日: ページ情報: 英文 1200 Pages
概要

当レポートでは、世界の癌診断検査市場について調査分析し、新興の検査、技術、装置、売上高予測(国別)、主要サプライヤーの戦略的プロファイルなどを提供して、概略以下の構成でお届けいたします。

第1章 世界のビジネス環境

第2章 世界の市場構造

第3章 主な現在/新興の癌診断検査

  • イントロダクション
  • 腫瘍マーカーの分類
  • ACTH
  • アルファフェトプロテイン(AFP)
  • β2ミクログロブリン
  • CA 15-3/27.29
  • CA 19-9
  • CA-125
  • カルシトニン
  • 癌胎児性抗原(CEA)
  • エストロゲン・プロゲステロン受容体
  • フェリチン
  • ガストリン
  • ヒト絨毛性ゴナドトロピン(HCG)
  • インスリン
  • NSE
  • 潜血
  • パップスメア/HPV
  • 前立腺酸性フォスファターゼ(PAP)
  • 前立腺特異抗原(PSA)
  • 扁平上皮癌関連抗原(SCC)
  • T・Bリンパ球
  • TdT
  • サイログロブリン
  • 組織ポリペプチド抗原(TPA)
  • 生化学腫瘍マーカー
  • 腫瘍遺伝子
  • ポリペプチド増殖因子
  • 異所性ホルモン
  • コロニー刺激因子
  • リンフォカイン
  • 免疫組織化学染色
  • 新興の腫瘍マーカー

第4章 装置レビュー

第5章 現在/新興の技術

  • モノクローナル・ポリクローナル抗体
  • 免疫測定
  • 分子診断
  • 染色体分析
  • 人工知能
  • フローサイトメトリー
  • 二次元ゲル電気泳動(2-DGE)
  • バイオセンサー
  • 競合/補完技術

第6章 競合企業プロファイル

  • Abbott
  • AdnaGen
  • Applied Gene Technologies
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • Biomedical Diagnostics
  • bioMerieux
  • Bio-Rad
  • CellSearch
  • Cepheid
  • Dako
  • Decode
  • Diadexus
  • Diagnocure
  • Diasorin
  • 栄研化学
  • Enterix
  • Enzo Biochem
  • Epigenomics
  • Exact Sciences
  • 富士レビオ
  • Gen-Probe
  • Guided Therapeutics
  • Hologic
  • Kreatech
  • 協和メデックス
  • Life Technologies
  • Mackay Life Sciences
  • Myriad Genetics
  • Nanogen Elitech
  • Nuvelo
  • OncoLab
  • Ortho-Clinical Diagnostics
  • Panacea Pharmaceuticals
  • Polartechnics
  • Polymedco
  • PreMD
  • Qiagen/Ipsogen
  • Radient Pharmaceuticals
  • Roche
  • Scienion
  • Sequenom
  • Siemens Healthcare
  • タカラバイオ
  • Targeted Diagnostics & Therapeutics
  • 東ソー
  • Vermillion/Correlogic Systems
  • 和光純薬工業
  • Wallac/PE
  • Zila

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: VPTM18380

The report is available by country, section, market segment, and can be custom-tailored to your specific information needs and budget.

VPGMarketResearch's new study of the major business opportunities emerging in the global cancer diagnostics market during the next five years examines trends in the U.S., Europe and Asia; reviews current and emerging assays; analyzes potential applications of new diagnostic technologies; forecasts sales of major tumor markers by country and market segment; profiles leading players and potential market entrants; and identifies specific business opportunities for suppliers.

Rationale

The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the worldwide cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in geriatric population will further compound the growing demand for malignancy assays and the rapid market expansion worldwide.

Geographic Coverage

France, Germany, Italy, Japan, Spain, UK, USA

Worldwide Market Overview

- Five-year test volume and sales projections by country.

- Comprehensive market segmentation analysis, including review of the market dynamics, structure, size, growth and major suppliers by country.

- Estimated universe of laboratories performing cancer diagnostic testing by country.

- Cancer statistics, etiology and recent developments in the U.S., Europe, and Asia.

Business Opportunities and Strategic Recommendations

- Specific new product development opportunities with potentially significant market appeal during the next five years.

- Design criteria for new products.

- Alternative market penetration strategies.

- Potential market entry barriers and risks.

Over 200 Current and Emerging Cancer Diagnostic Test

- Oncogenes Biochemical Markers Growth Factors Colony Stimulating Factors Hormones Immunohistochemical Stains Lymphokines

Supplier Shares, Sales and Volume Forecasts

- Sales and market shares of major cancer diagnostic product suppliers by individual test and country.

- Five-year test volume and sales forecasts for major tumor markers by country and market segment, including:

     º  Hospitals      º  Commercial/Private Laboratories      º  Physician Offices/Group Practices      º  Cancer Clinics      º  Ambulatory Care Centers

Instrumentation Review

- Analysis of major molecular diagnostic and immunodiagnostic analyzers used for cancer testing, including their operating characteristics, features and selling prices.

Technology Assessment

- Assessment of latest technologies and their potential applications for cancer diagnostic testing.

- Review of competing/complementing technologies.

- Extensive listings of companies, universities and research centers developing new cancer diagnostic tests and detection technologies.

Competitive Strategies

- Strategic assessments of major suppliers and start-up firms developing innovative cancer diagnostic technologies and products, including their sales, product portfolios, marketing tactics, collaborative arrangements, and new products in R&D.

- The companies analyzed in the report include:

   - Abbott    - AdnaGen    - Agilent Technologies    - Applied Gene Technologies    - Arca Biopharma    - Beckman Coulter/Danaher    - Becton Dickinson    - Biomedical Diagnostics/Theradiag    - bioMerieux    - Bio-Rad    - CellSearch    - Cepheid    - Correlogic Systems/Vermillion    - Decode Genetics    - Diadexus    - Diagnocure    - DiaSorin    - Eiken Chemical    - Elitech Group    - Enterix    - Enzo Biochem    - Epigenomics    - Exact Sciences    - Fujirebio    - Guided Therapeutics    - Hologic/Gen-Probe    - Kreatech/Leica    - Kyowa Medex    - Mackay Life Sciences    - Myriad Genetics    - OncoLab    - Ortho-Clinical Diagnostics    - Panacea Pharmaceuticals    - Polartechnics    - Polymedco    - PreMD    - Qiagen    - Quest Diagnostics    - Radient Pharmaceuticals    - Roche    - Scienion    - Sequenom    - Siemens Healthcare    - Takara Bio    - Targeted Diagnostics & Therapeutics    - Thermo Fisher    - Tosoh    - Veridex    - Wako Pure Chemicals    - Wallac/PE    - Zilla

Contains: 1,200 pages and 450 tables

Table of Contents

I. Worldwide Business Environment

II. Worldwide Market Structure

III. Major Current And Emerging Cancer Diagnostic Tests

  • 1. Introduction
  • 2. Tumor Marker Classification
  • 3. ACTH
  • 4. Alpha-Fetoprotein (AFP)
  • 5. Beta-2 Microglobulin
  • 6. CA 15-3/27.29
  • 7. CA 19-9
  • 8. CA-125
  • 9. Calcitonin
  • 10. Carcinoembrionic Antigen (CEA)
  • 11. Estrogen and Progesterone Receptors
  • 12. Ferritin
  • 13. Gastrin
  • 14. Human Chorionic Gonadotropin (HCG)
  • 15. Insulin
  • 16. NSE
  • 17. Occult Blood
  • 18. PAP Smear/HPV
  • 19. Prostatic Acid Phosphatase (PAP)
  • 20. Prostate-Specific Antigen (PSA)
  • 21. Squamous Cell Carcinoma Antigen (SCC)
  • 22. T and B Lymphocytes
  • 23. TdT
  • 24. Thyroglobulin
  • 25. Tissue Polypeptide Antigen (TPA)
  • 26. Biochemical Tumor Markers
    • ADA
    • B-Protein
    • PNP
    • 5'-Nucleotidase
  • 27. Oncogenes
    • Abl/abl-bcr
    • AIB1
    • BCL-2
    • BRCA1
    • CD44
    • C-fos
    • C-myb
    • C-myc
    • CYP-17
    • Erb-B
    • HPC1
    • N-myc
    • P40
    • P51
    • P53
    • PIK3CA
    • PTI-1
    • Ras
    • Reg
    • Sis
    • Src
  • 28. Polypeptide Growth Factors
    • Basic Fibroblast Growth Factor
    • Beta-TGF
    • Cachectin (TNT)
    • Calmodulin
    • ECFR
    • Nerve Growth Factor (NGF)
    • Epidermal Growth Factor (EGF)
    • Ornithine Decarboxylase
    • Transferrin
    • Transforming Growth Factor-Alpha
  • 29. Ectopic Hormones
  • 30. Colony Stimulating Factors
  • 31. Lymphokines
    • Alpha-Interferon
    • B Cell Growth Factors
    • B Cell Growth Factor (BCGF)
    • Gamma-Interferon
    • Interleukin-1 (IL-1)
    • Macrophage Activating Factor
  • 32. Immunohistochemical Stains
  • 33. Emerging Tumor Markers
    • N-Acetylglucosamine
    • Actin
    • Alpha-Actin
    • Antineuronal Antibodies
    • 7B2
    • B72.3
    • Bax
    • BCD-F9
    • BLCA-4
    • Blood Group Antigens A,B,H
    • CA 50
    • CA 72-4/TAG-72
    • CA 195
    • CA-242
    • CA-549
    • CAM 26
    • CAR-3
    • Cathepsin-D
    • Chromogranin A and B
    • Cluster 1 Antigen
    • Cluster-5/5A Antigen
    • CTA
    • CU18
    • DR-70
    • DU-PAN-2
    • Endometrial Bleeding Associated Factor
    • Endostatin
    • Epithelial Membrane Antigen
    • Feulgen Hydrolysis
    • Fibronectin
    • FSH
    • (1->3)-L-fucosyltransferase
    • Gastrin-Releasing Peptide (GRP)
    • GDCFP-15
    • Glucagon
    • Glycoamines
    • H23
    • Her-2
    • Human Carcinoma Antigen
    • HPA
    • HSP27
    • Intermediate Filaments
    • Cytokeratins/CK18/Cyfra 21-1
    • Desmin
    • Gliofibrillary Acid Protein
    • Neurofilaments
    • Vimentin
    • KA 93
    • Kinases
    • KP16D3
    • LAI
    • Leukocyte Common Antigen
    • Lewis Antigens
    • Lysophosphatidic Acid (LPA)
    • Ma 695/Ma 552
    • MABDF3
    • MAG
    • ME1
    • Minactivin
    • MN/CA9
    • MSA
    • Mucin Cancer Antigen (MCA)
    • Multiple Tumor Suppressor 1
    • Myosin
    • NEA-130
    • NMP22
    • OA-519
    • Opiod Peptides
    • P-glycoprotein
    • Pancreatic Oncofetal Antigen (POA)
    • Placental Lactogen
    • PR92
    • Proliferative Index, Ki-67
    • Px
    • RB Inactivation/Deletion
    • Ret
    • SCCL 175
    • Selectin
    • Sialic Acid
    • Sialyl SSEA-1/SLX
    • SN10
    • Somatostatin
    • TA-90
    • TABA
    • Tachykinin
    • TAG 12
    • TPS
    • Troponin
    • Tubulin
    • VCAM
    • VEGF
    • Villen

IV. Instrumentation Review: Leading Analyzers Marketed by Abbott, Beckman Coulter/Danaher, Binding Site, bioMerieux, Carolina Chemistries, DiaSorin, Horiba, Inverness/Alere, J&J, Olympus, Roche, Siemens, Tosoh, Vital Diagnostics and other suppliers

V. Current and Emerging Technologies

  • 1. Monoclonal and Polyclonal Antibodies
  • 2. Immunoassays
    • a. Technological Principle
    • b. Radioimmunoassay (RIA)
    • c. Enzyme Immunoassays (EIA)
      • Overview
      • ELISA
      • Immunofiltration
      • Particle-Membrane Capture Immunoassay
      • Enzyme Amplification
    • d. Fluorescent Immunoassays
    • e. Luminescence
      • Chemiluminescence
      • Bioluminescence
    • f. Latex Agglutination
    • g. Immunoprecipitation
      • H. Affinity Chromatographu
      • e. Liposome Flow-Injection Immunoassay
  • 3. Molecular Diagnostics
    • a. Technology Overview
    • b. Amplification Methods
      • PCR
      • DAP-PCR
      • Immuno-PCR
      • QC-PCR
      • CAR
      • DNA
      • HPA
      • LCR
      • NASBA
      • QBR
      • SDA
      • 3 SR, and others
  • 4. Chromosome Analysis
    • a. Chronic Myelogenous Leukemia (CML)
    • b. Acute Myeloid Leukemia (AML)
    • c. Acute Lymphoblastic Leukemia (ALL)
    • d. Malignant Lymphomas Lymphoid Malignancies
    • e. Chronic Lymphocytic Leukemia (CLL)
    • f. Solid Cancers
    • g. Chromosomal Translocation and Oncogenes
  • 5. Artificial Intelligence
  • 6. Flow Cytometry
  • 7. Two Dimensional Gel Electrophoresis (2-DGE)
  • 8. Biosensors
  • 9. Competing/Complementing Technologies
    • a. CT
    • b. MRI
    • c. NMR
    • d. PET
    • e. Photonics Spectroscopy

VI. Competitive Profiles

  • Abbott
  • AdnaGen
  • Applied Gene Technologies
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • Biomedical Diagnostics
  • bioMerieux
  • Bio-Rad
  • CellSearch
  • Cepheid
  • Dako
  • Decode
  • Diadexus
  • Diagnocure
  • Diasorin
  • Eiken Chemical
  • Enterix
  • Enzo Biochem
  • Epigenomics
  • Exact Sciences
  • Fujirebio
  • Gen-Probe
  • Guided Therapeutics
  • Hologic
  • Kreatech
  • Kyowa Medex
  • Life Technologies
  • Mackay Life Sciences
  • Myriad Genetics
  • Nanogen Elitech
  • Nuvelo
  • OncoLab
  • Ortho-Clinical Diagnostics
  • Panacea Pharmaceuticals
  • Polartechnics
  • Polymedco
  • PreMD
  • Qiagen/Ipsogen
  • Radient Pharmaceuticals
  • Roche
  • Scienion
  • Sequenom
  • Siemens Healthcare
  • Takara Bio
  • Targeted Diagnostics & Therapeutics
  • Tosoh
  • Vermillion/Correlogic Systems
  • Wako Pure Chemicals
  • Wallac/PE
  • Zila

Appendixes: Major Universities and Research Centers Developing Cancer Diagnostic Technologies and Applications

List of Tables

  • Tumor Marker Classification
  • Major Companies Developing or Marketing ACTH Tests
  • Major Companies Developing or Marketing AFP Tests
  • Major Companies Developing or Marketing Beta-2 Microglobulin Tests
  • Major Companies Developing or Marketing CA 15-3/27.29 Tests
  • Major Companies Developing or Marketing CA 19-9 Tests
  • Major Companies Developing or Marketing CA 125 Tests
  • Major Companies Developing or Marketing Calcitonin Tests
  • Major Companies Developing or Marketing CEA Tests
  • Major Companies Developing or Marketing Estrogen Receptor Tests
  • Major Companies Developing or Marketing Progesterone Receptor Tests
  • Major Companies Developing or Marketing Ferritin Tests
  • Major Companies Developing or Marketing Gastrin Tests
  • Major Companies Developing or Marketing HCG Tests
  • Major Companies Developing or Marketing Insulin Tests
  • Major Companies Developing or Marketing NSE Tests
  • Major Companies Developing or Marketing Occult Blood Tests
  • Major Companies Developing or Marketing PAP Smear/HPV Tests
  • Major Companies Developing or Marketing PAP Tests
  • Major Companies Developing or Marketing PSA Tests
  • Major Companies Developing or Marketing Lymphocyte Subclassification Tests
  • Biochemical Markers Potential Applications In Cancer Diagnosis
  • Oncogenes Potential Applications In Cancer Diagnosis
  • Major Companies Developing or Marketing Oncogene Tests
  • Growth Factors Potential Applications In Cancer Diagnosis
  • Colony Stimulating Factors Potential Applications in Cancer Diagnosis
  • Lymphokines Potential Applications In Cancer Diagnosis
  • Immunohistochemical Stains Potential Applications in Cancer Diagnosis
  • Worldwide, All Market Segments, Laboratories Performing Cancer Diagnostic Testing By Country
  • Worldwide, All Market Segments, Cancer Diagnostic Test Volume Forecasts By Country
  • Worldwide, All Market Segments, Cancer Diagnostics Sales Forecasts By Country
Back to Top